Clinical guidelines and consensus statements make recommendations on the appropriate treatment and care of myeloma patients based on current available evidence. Their aim is to guide decision making to improve the outcomes for patients, ensure healthcare resources are used efficiently and help reduce variation in practice.

Listed are current guidelines from BSH, UKMF, EMN, IMWG and NICE.

Reviewed January 2020